221 related articles for article (PubMed ID: 1080490)
1. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.
Cooper HA; Reisner FF; Hall M; Wagner RH
J Clin Invest; 1975 Sep; 56(3):751-60. PubMed ID: 1080490
[TBL] [Abstract][Full Text] [Related]
2. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
Switzer ME; McKee PA
J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
[TBL] [Abstract][Full Text] [Related]
3. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
Switzer ME; McKee PA
J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
[TBL] [Abstract][Full Text] [Related]
4. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
Orthner CL
J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
[TBL] [Abstract][Full Text] [Related]
5. Molecular structural studies of human factor VIII.
McKee PA; Andersen JC; Switzer ME
Ann N Y Acad Sci; 1975 Jan; 240():8-33. PubMed ID: 122889
[TBL] [Abstract][Full Text] [Related]
6. The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.
Cooper HA; Wagner RH
J Clin Invest; 1974 Nov; 54(5):1093-9. PubMed ID: 4213756
[TBL] [Abstract][Full Text] [Related]
7. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
Hoyer LW; Trabold NC
J Lab Clin Med; 1981 Jan; 97(1):50-64. PubMed ID: 6778941
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
Tran TH; Duckert F
Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
[TBL] [Abstract][Full Text] [Related]
9. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
10. The subunit structure of normal and hemophilic factor VIII.
Shapiro GA; Andersen JC; Pizzo SV; McKee PA
J Clin Invest; 1973 Sep; 52(9):2198-210. PubMed ID: 4199414
[TBL] [Abstract][Full Text] [Related]
11. The properties of immune complexes formed by human antibodies to factor VIII.
Lazarchick J; Hoyer LW
J Clin Invest; 1977 Nov; 60(5):1070-9. PubMed ID: 908750
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.
Koedam JA; Meijers JC; Sixma JJ; Bouma BN
J Clin Invest; 1988 Oct; 82(4):1236-43. PubMed ID: 2971673
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
Kirby EP
Thromb Haemost; 1981 Aug; 46(2):479-84. PubMed ID: 6795738
[TBL] [Abstract][Full Text] [Related]
14. Factor VIII and human platelet aggregation. IV. Effect of proteolytic enzymes on platelet aggregation by factor VIII.
Vermylen J; Bottecchia D
Br J Haematol; 1976 Oct; 34(2):331-40. PubMed ID: 135576
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
16. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
Bennett B; Forman WB; Ratnoff OD
J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of factor VIII by a mechanism independent of the generation of thrombin.
Triantaphyllopoulos DC
Thromb Haemost; 1979 Oct; 42(3):838-47. PubMed ID: 505401
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of the Factor-VIII complex during clotting: role of thrombin and phospholipids.
Muntean W; Rothwangl HJ
Eur J Clin Invest; 1984 Dec; 14(6):462-8. PubMed ID: 6441724
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of factor VIII in the presence of proteolytic inhibitors.
Sussman II; Weiss HJ
Thromb Haemost; 1978 Oct; 40(2):316-25. PubMed ID: 310586
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of factor VIII inactivation by human antibodies. IV. Antibody binding prevents factor VIII proteolysis by thrombin.
Lazarchick J; Ashby MA; Lazarchick JJ; Sens DA
Ann Clin Lab Sci; 1986; 16(6):497-501. PubMed ID: 3099625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
